NYU Langone Health
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, NYU Langone Health sits in the top decile of US sponsors by registered trial count (#25 of 15,742 sponsors by registered trial count).
NYU Langone Health: 1,164 sponsored US clinical trials, 197 recruiting.
NYU Langone Health sponsors 1,164 registered US clinical trials on ClinicalTrials.gov, 197 of them currently recruiting, and 741 completed. 123 of these trials are in Phase 3-4 (later-stage) and 231 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 12 trials.
Top-decile sponsor footprint
NYU Langone Health ranks in the top decile of sponsors by registered trial count (#25 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
741 of 866 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,164 total, page 14 of 24
RELAXaHEAD for Headache Patients (Phase I)
NCT03183791
Child-Physician Recommendation on Parental Adherence to Colorectal Cancer Screening
NCT03304860
Reduction of Pro-Inflammatory Synovial Fluid Biomarkers in Osteoarthritis of the Knee With Alpha-2 Macroglobulin
NCT03656575
The Effect of Distractive Auditory Stimuli (Music) on Dyspnea and Anxiety During Exercise in Adults With Chronic Respiratory Diseases
NCT02955108
A Phase II a Study of Lenvatinib, a Multi-targeted Tyrosine Kinase Inhibitor, Combined With Pembrolizumab (PD-1 Inhibitor) for the Treatment of Metastatic Gastroesophageal Cancer Patients Who Have Progressed on First or Subsequent Line Therapies
NCT03321630
Comparative Analysis of Transperineal Versus Transrectal Approaches for MRI-Targeted Biopsy of the Prostate for the Detection and Characterization of Prostate Cancer
NCT03366792
Effects of Diet on Pregnancy Outcome and Child Obesity
NCT03232762
Feasibility Study of Telemedicine for Dialysis Patients Awaiting Transplantation
NCT03189212
The Poweroff Sleep Study
NCT03364101
Integrating Financial Management Counseling and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants
NCT03187730
Gravity Flow Technique to Validate Proper Location of Epidural Needle Tip
NCT03317626
Investigating and Characterizing the Immune Response to Prostate Cancer
NCT03331367
Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase
NCT03148782
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
NCT03089515
Ferric Carboxymaltose to Improve Skeletal Muscle Metabolism in Heart Failure Patients With Functional Iron Deficiency
NCT03218384
Early Weight Bearing for Unstable Ankle Fractures Undergoing Operative Stabilization
NCT02779244
Zoster Eye Disease Study
NCT03134196
High-intensity Group Vocal Exercise to Improve Laryngeal Function in Patients With Parkinson Disease
NCT03263793
Levetiracetam in Early Psychosis
NCT03129360
Advancing People of Color in Clinical Trials Now: Involvement in Trials Using a Patient-Centered Website: A Community-Engaged Approach
NCT03243071
Imaging Non-brain Electromagnetic Activity in Healthy Adults Using MEG
NCT03232723
Subclinical Cardiovascular Disease in Psoriatic Disease
NCT03228017
Feasibility and Efficacy of Assisstive Tactile and Auditory Communicating Devices
NCT03174314
A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings ("CDE-EHR-PC" Study), Phase 1
NCT02974335
Metabolic Sodium MRI to Assess Early Response of Breast Cancer to Neoadjuvant Chemotherapy
NCT03750240
Anterior Orientation vs Posterior Orientation in Per Oral Endoscopic Myotomy POEM for the Treatment of Achalasia
NCT03228758
Visual Spatial Exploration and Art Therapy Intervention in Patients Diagnosed With Parkinson's Disease
NCT03178786
Educating the Educator to Reduce Risk of Dance Student Injury
NCT03223259
The Use of Serratus Block for Cardiac Surgery
NCT03237546
Integrating Community Health Workers to Improve Diabetes Prevention
NCT03006666
Validation of Machine Learning Based Personalized Nutrition Algorithm to Reduce Postprandial Glycemic Excursions Among North American Individuals With Newly Diagnosed Type 2 Diabetes
NCT03053518
Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell Carcinoma
NCT03278626
Effects of Ondansetron in Obsessive-compulsive and Tic Disorders
NCT03239210
Effectiveness of the Astym Technique, the Graston Technique, and Therapeutic Ultrasound in the Treatment of Lateral Epicondylosis.
NCT03234192
A Study to Analyze the Effect of Acupuncture on Mobility And Quality of Life in Multiple Sclerosis
NCT03174379
The Confounding Burden of Psychological Impairments in Cervical Spine Surgery
NCT03183713
Study of Nonmyeloablative Peripheral Blood Stem Cell Transplant With High-dose Posttransplantation Cyclophosphamide in Hematopoietic Malignancies Including Those That Are Challenging to Engraft
NCT03187756
Early Independent Adaptive Arm and Hand Rehab
NCT02749500
Assessing the Impact of Acupuncture Therapy on Medical Resident Well-Being: Feasibility and Acceptance
NCT03245034
Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery
NCT03048578
Caregiver-Child Interaction and Health Behaviors
NCT03162822
pH-weighted MRI in Multiple Sclerosis: A Surrogate Marker of Tissue Metabolic Stress
NCT03028675
Couple Interaction and Health Behaviors
NCT03163082
Promoting Safe Use of Children's Cough/Cold Medicines
NCT03126851
A Study Investigating the Efficacy of Various Wound Closure Devices in Reducing Postoperative Wound Complications
NCT03134209
A Pilot Study of Prostate Cancer-specific Anxiety in Active Surveillance
NCT03227744
Leveraging Technology to Address Unhealthy Drug Use in Primary Care Settings
NCT02893514
Buccal Mucosa Healing Trial With Tissue Matrix Placement
NCT02768467
Health Information Technology in Heart Failure Care
NCT02858674
Use of Low Cost Prostheses to Improve Upper Extremity Function in Children With Cerebral Palsy
NCT03122171
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 99 |
| Phase 2 | 132 |
| Phase 3 | 28 |
| Phase 4 | 95 |
Therapeutic Areas
What is open in the NYU Langone Health pipeline
197 recruiting of 1,164 indexed (17% open); 741 completed (64%).
Phase mix: 123 late (III/IV) vs 231 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
NYU Langone Health: open-pipeline peers nationwide
Peers matched on 1,164 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
NYU Langone Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,164 trials (± recruiting share)
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- Northwestern University · 1,209 trials · 15% recruiting
Sponsors near 17% open enrollment (± trial volume)
- CSL Behring · 17% recruiting · 71 trials
- Penn State University · 17% recruiting · 219 trials
- University of Hawaii · 17% recruiting · 77 trials
- University of Utah · 17% recruiting · 818 trials
Related
What to do with this NYU Langone Health page
1,164 registered trials is a research-attention snapshot, not an endorsement of NYU Langone Health or any single study.
- 197 of NYU Langone Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition NYU Langone Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
NYU Langone Health pipeline card: 1,164 registered trials from official public datasets.Report a data error.